Artiva Biotherapeutics, Inc.
ARTV- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817241
In the last 90 days, Artiva Biotherapeutics, Inc. insiders filed 5 open-market purchases and 7 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $391.6M in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in Artiva Biotherapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +7 vs. Q4 2025
- Shares held
- 16.8M
- +124.3K (+0.7%) vs. Q4 2025
- Total value
- $108.4M
- +$36.7M (+51.2%) vs. Q4 2025
- New holders
- 12
- 3 more added
- Sold out
- 5
- 12 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARTV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 72 | $391.6M |
| Q1 2026 | 40 | $108.4M |
| Q4 2025 | 34 | $72.7M |
| Q3 2025 | 40 | $52.1M |
| Q2 2025 | 48 | $27.9M |
| Q1 2025 | 53 | $62.8M |
| Q4 2024 | 57 | $213.2M |
| Q3 2024 | 49 | $319.4M |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Artiva Biotherapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 18 | $116 | 0.00% | −14−43.8% | Reduced |
| Royal Bank of Canada | 188 | $1.00K | 0.00% | −151−44.5% | Reduced |
| JPMorgan Chase & Co | 223 | $1.22K | 0.00% | +36+19.3% | Added |
| BNP Paribas Arbitrage, SA | 542 | $3.49K | 0.00% | 00.0% | Unchanged |
| Mark Sheptoff Financial Planning, LLC | 400 | $4.24K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,500 | $9.66K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,527 | $9.83K | 0.00% | −35,346−95.9% | Reduced |
| FMR LLC | 3,529 | $22.7K | 0.00% | −29−0.8% | Reduced |
| Russell Investments Group, Ltd. | 5,491 | $35.4K | 0.00% | 00.0% | Unchanged |
| Omers Administration Corp | 11,400 | $73.4K | 0.00% | −9,700−46.0% | Reduced |
| Goldman Sachs Group Inc | 11,465 | $73.8K | 0.00% | −595−4.9% | Reduced |
| Northern Trust Corp | 12,208 | $78.6K | 0.00% | +12,208 | New |
| Citadel Advisors LLC | 15,870 | $102.2K | 0.00% | +15,870 | New |
| Morgan Stanley | 16,377 | $105.5K | 0.00% | −10,695−39.5% | Reduced |
| XTX Topco Ltd | 20,270 | $130.5K | 0.00% | +20,270 | New |
| Dimensional Fund Advisors LP | 20,370 | $131.2K | 0.00% | +20,370 | New |
| Bailard, Inc. | 20,700 | $133.3K | 0.00% | +20,700 | New |
| Sanctuary Advisors, LLC | 21,581 | $139.0K | 0.00% | +21,581 | New |
| Simplify Asset Management Inc. | 23,230 | $149.6K | 0.00% | +23,230 | New |
| Velan Capital Investment Management LP | 25,000 | $161.0K | 0.10% | +25,000 | New |
| Panagora Asset Management Inc | 30,702 | $197.7K | 0.00% | +30,702 | New |
| Vanguard Fiduciary Trust Co | 32,810 | $211.3K | 0.00% | +32,810 | New |
| Bridgeway Capital Management, LLC | 35,000 | $225.4K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 35,824 | $230.7K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 39,496 | $254.4K | 0.00% | −1,175−2.9% | Reduced |
| Renaissance Technologies LLC | 80,038 | $515.4K | 0.00% | −36,162−31.1% | Reduced |
| Alyeska Investment Group, L.P. | 100,000 | $644.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 101,695 | $655.5K | 0.00% | +578+0.6% | Added |
| Two Sigma Investments, LP | 115,041 | $740.9K | 0.00% | −29,823−20.6% | Reduced |
| Millennium Management LLC | 123,270 | $793.9K | 0.00% | −93,827−43.2% | Reduced |
| Propel Bio Management, LLC | 146,369 | $949.8K | 0.60% | +146,369 | New |
| Wellington Management Group LLP | 194,108 | $1.25M | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 207,686 | $1.34M | 0.00% | +207,686 | New |
| BlackRock, Inc. | 213,388 | $1.37M | 0.00% | +850+0.4% | Added |
| Revelation Capital Management, LLC | 299,311 | $1.93M | 2.86% | 00.0% | Unchanged |
| Franklin Resources Inc | 520,327 | $3.35M | 0.00% | 00.0% | Unchanged |
| venBio Partners LLC | 531,337 | $3.42M | 1.22% | −117,170−18.1% | Reduced |
| VR Adviser, LLC | 1,609,569 | $10.4M | 0.39% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 2,353,304 | $15.2M | 4.21% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 9,853,302 | $63.5M | 0.67% | 00.0% | Unchanged |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −79,559−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −27,757−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −10,691−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,103−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −113−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |